GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (XBRU:SEQUA) » Definitions » EBITDA Margin %

Sequana Medical NV (XBRU:SEQUA) EBITDA Margin % : -3,634.64% (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sequana Medical NV's EBITDA for the six months ended in Jun. 2023 was €-13.96 Mil. Sequana Medical NV's Revenue for the six months ended in Jun. 2023 was €0.38 Mil. Therefore, Sequana Medical NV's EBITDA margin for the quarter that ended in Jun. 2023 was -3,634.64%.


Sequana Medical NV EBITDA Margin % Historical Data

The historical data trend for Sequana Medical NV's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV EBITDA Margin % Chart

Sequana Medical NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -1,259.18 -1,424.00 -1,824.20 -5,998.11 -3,161.97

Sequana Medical NV Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49,017.39 -3,154.89 -2,817.46 -3,517.90 -3,634.64

Competitive Comparison of Sequana Medical NV's EBITDA Margin %

For the Medical Devices subindustry, Sequana Medical NV's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequana Medical NV's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's EBITDA Margin % falls into.



Sequana Medical NV EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sequana Medical NV's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-29.185/0.923
=-3,161.97 %

Sequana Medical NV's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-13.957/0.384
=-3,634.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sequana Medical NV  (XBRU:SEQUA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Sequana Medical NV EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequana Medical NV (XBRU:SEQUA) Business Description

Traded in Other Exchanges
Address
Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (XBRU:SEQUA) Headlines

No Headlines